Volatile Organic Metabolites Identify Patients with Breast Cancer, Cyclomastopathy, and Mammary Gland Fibroma

[1]  J. Ludden,et al.  Principles and Practice , 1998, Community-based Learning and Social Movements.

[2]  许国旺,et al.  Volatile organic metabolites identify patients with breast cancer; cyclomastopathy; and mammary gland fibroma , 2014 .

[3]  I. Jatoi,et al.  The global breast cancer burden. , 2012, Future oncology.

[4]  Ulrike Tisch,et al.  Classification of lung cancer histology by gold nanoparticle sensors. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[5]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[6]  B. Vidakovic,et al.  Breath Analysis by Mass Spectrometry: A New Tool for Breast Cancer Detection? , 2011, The American surgeon.

[7]  Howard Wainer,et al.  How should we screen for breast cancer? , 2011 .

[8]  Ulrike Tisch,et al.  Classification of breast cancer precursors through exhaled breath , 2011, Breast Cancer Research and Treatment.

[9]  Massimo Corradi,et al.  Determination of aldehydes in exhaled breath of patients with lung cancer by means of on-fiber-derivatisation SPME-GC/MS. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[10]  H. Haick,et al.  Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors , 2010, British Journal of Cancer.

[11]  M. Phillips,et al.  Volatile biomarkers in the breath of women with breast cancer , 2010, Journal of breath research.

[12]  G. Sun,et al.  Quantitative breath analysis of volatile organic compounds of lung cancer patients. , 2010, Lung cancer.

[13]  P. Galan,et al.  Metabolite analysis of human fecal water by gas chromatography/mass spectrometry with ethyl chloroformate derivatization. , 2009, Analytical biochemistry.

[14]  M. Fiegl,et al.  Noninvasive detection of lung cancer by analysis of exhaled breath , 2009, BMC Cancer.

[15]  L. Ferguson,et al.  Nontargeted urinary metabolite profiling of a mouse model of Crohn's disease. , 2009, Journal of proteome research.

[16]  Sabine Kischkel,et al.  Impact of sampling procedures on the results of breath analysis , 2008, Journal of breath research.

[17]  K. Mokbel,et al.  Oestrogen producing enzymes and mammary carcinogenesis: a review , 2008, Breast Cancer Research and Treatment.

[18]  J. Listinsky,et al.  How should we screen for breast cancer? Mammography, ultrasonography, MRI. , 2007, Cleveland Clinic journal of medicine.

[19]  Ping Wang,et al.  A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis , 2007, Cancer.

[20]  R. Bernhardt,et al.  Cytochrome P450 systems--biological variations of electron transport chains. , 2007, Biochimica et biophysica acta.

[21]  W. Miekisch,et al.  A novel visually CO2 controlled alveolar breath sampling technique. , 2006, Technology and health care : official journal of the European Society for Engineering and Medicine.

[22]  T. Wolfson,et al.  The efficacy of breast MRI in predicting breast conservation therapy , 2006, Journal of surgical oncology.

[23]  Yoshinobu Sato,et al.  Preoperative Evaluation of Residual Tumor Extent by Three‐Dimensional Magnetic Resonance Imaging in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy , 2006, The breast journal.

[24]  Yoshinobu Sato,et al.  Preoperative Evaluation of Residual Tumor Extent by Three‐Dimensional Magnetic Resonance Imaging in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy , 2006, The breast journal.

[25]  H. Hollema,et al.  Aromatase in the context of breast and endometrial cancer. A review. , 2006, Minerva endocrinologica.

[26]  C. D'Orsi,et al.  Diagnostic Performance of Digital Versus Film Mammography for Breast-Cancer Screening , 2005, The New England journal of medicine.

[27]  P. Goss,et al.  The role of COX-2 inhibition in breast cancer treatment and prevention. , 2004, Seminars in oncology.

[28]  M. Phillips,et al.  Volatile Markers of Breast Cancer in the Breath , 2003, The breast journal.

[29]  S. Woolf,et al.  Breast Cancer Screening: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.

[30]  Ingvar Andersson,et al.  Long-term effects of mammography screening: updated overview of the Swedish randomised trials , 2002, The Lancet.

[31]  R. Brueggemeier,et al.  Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[32]  M. Phillips,et al.  Effect of age on the breath methylated alkane contour, a display of apparent new markers of oxidative stress. , 2000, The Journal of laboratory and clinical medicine.

[33]  L. Tabár,et al.  The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. , 2000, Radiologic clinics of North America.

[34]  M. J. van de Vijver,et al.  Diagnosis of breast cancer: contribution of US as an adjunct to mammography. , 1999, Radiology.

[35]  P. Skaane.  The Additional Value of us to Mammography in the Diagnosis of Breast Cancer , 1999, Acta radiologica.

[36]  J. Knight.  Free radicals: their history and current status in aging and disease. , 1998, Annals of clinical and laboratory science.

[37]  S. Chen,et al.  Aromatase and breast cancer. , 1998, Frontiers in bioscience : a journal and virtual library.

[38]  J. Liehr,et al.  4-Hydroxylation of estrogens as marker of human mammary tumors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  C. Jefcoate,et al.  The effects of 2,3,7,8-Tetrachlorodibenzo-p-dioxin on estrogen metabolism in MCF-7 breast cancer cells: Evidence for induction of a novel 17β-estradiol 4-hydroxylase , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[40]  C. Kneepkens,et al.  The potential of the hydrocarbon breath test as a measure of lipid peroxidation. , 1994, Free radical biology & medicine.

[41]  S. Wall,et al.  Breast cancer screening with mammography: overview of Swedish randomised trials , 1993, The Lancet.

[42]  C. Kneepkens,et al.  The hydrocarbon breath test in the study of lipid peroxidation: principles and practice. , 1992, Clinical and investigative medicine. Medecine clinique et experimentale.

[43]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[44]  L. Tabár,et al.  REDUCTION IN MORTALITY FROM BREAST CANCER AFTER MASS SCREENING WITH MAMMOGRAPHY Randomised Trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare , 1985, The Lancet.

[45]  Robert C. Wolpert,et al.  A Review of the , 1985 .